-
Je něco špatně v tomto záznamu ?
Cobalt Bis-Dicarbollide Enhances Antibiotics Action towards Staphylococcus epidermidis Planktonic Growth Due to Cell Envelopes Disruption
E. Vaňková, K. Lokočová, P. Kašparová, R. Hadravová, I. Křížová, O. Maťátková, J. Masák, V. Šícha
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
CZ.02.1.01/0.0/0.0/17_048/0007411
European Regional Development Fund ERDF/ESF Project "UniQSurf - Centre of biointerfaces and hybrid functional materials"
CZ.02.1.01/0.0/0.0/16_019/0000729
European Regional Development Fund; OP RDE
61388963
RVO project
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2004
Europe PubMed Central
od 2004
ProQuest Central
od 2004-01-01
Open Access Digital Library
od 2004-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2004
PubMed
35631360
DOI
10.3390/ph15050534
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
The emergence of antibiotic resistance in opportunistic pathogens represents a huge problem, the solution for which may be a treatment with a combination of multiple antimicrobial agents. Sodium salt of cobalt bis-dicarbollide (COSAN.Na) is one of the very stable, low-toxic, amphiphilic boron-rich sandwich complex heteroboranes. This compound has a wide range of potential applications in the biological sciences due to its antitumor, anti-HIV-1, antimicrobial and antibiofilm activity. Our study confirmed the ability of COSAN.Na (in the concentration range 0.2-2.48 μg/mL) to enhance tetracycline, erythromycin, and vancomycin action towards Staphylococcus epidermidis planktonic growth with an additive or synergistic effect (e.g., the combination of 1.24 μg/mL COSAN.Na and 6.5 μg/mL TET). The effective inhibitory concentration of antibiotics was reduced up to tenfold most efficiently in the case of tetracycline (from 65 to 6.5 μg/mL). In addition, strong effect of COSAN.Na on disruption of the cell envelopes was determined using propidium iodide uptake measurement and further confirmed by transmission electron microscopy. The combination of amphiphilic COSAN.Na with antibiotics can therefore be considered a promising way to overcome antibiotic resistance in Gram-positive cocci.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017306
- 003
- CZ-PrNML
- 005
- 20230601084524.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ph15050534 $2 doi
- 035 __
- $a (PubMed)35631360
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vaňková, Eva $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic $1 https://orcid.org/0000000188630696
- 245 10
- $a Cobalt Bis-Dicarbollide Enhances Antibiotics Action towards Staphylococcus epidermidis Planktonic Growth Due to Cell Envelopes Disruption / $c E. Vaňková, K. Lokočová, P. Kašparová, R. Hadravová, I. Křížová, O. Maťátková, J. Masák, V. Šícha
- 520 9_
- $a The emergence of antibiotic resistance in opportunistic pathogens represents a huge problem, the solution for which may be a treatment with a combination of multiple antimicrobial agents. Sodium salt of cobalt bis-dicarbollide (COSAN.Na) is one of the very stable, low-toxic, amphiphilic boron-rich sandwich complex heteroboranes. This compound has a wide range of potential applications in the biological sciences due to its antitumor, anti-HIV-1, antimicrobial and antibiofilm activity. Our study confirmed the ability of COSAN.Na (in the concentration range 0.2-2.48 μg/mL) to enhance tetracycline, erythromycin, and vancomycin action towards Staphylococcus epidermidis planktonic growth with an additive or synergistic effect (e.g., the combination of 1.24 μg/mL COSAN.Na and 6.5 μg/mL TET). The effective inhibitory concentration of antibiotics was reduced up to tenfold most efficiently in the case of tetracycline (from 65 to 6.5 μg/mL). In addition, strong effect of COSAN.Na on disruption of the cell envelopes was determined using propidium iodide uptake measurement and further confirmed by transmission electron microscopy. The combination of amphiphilic COSAN.Na with antibiotics can therefore be considered a promising way to overcome antibiotic resistance in Gram-positive cocci.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lokočová, Kristýna $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic
- 700 1_
- $a Kašparová, Petra $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic
- 700 1_
- $a Hadravová, Romana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 166 10 Prague, Czech Republic
- 700 1_
- $a Křížová, Ivana $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic $1 https://orcid.org/0000000204974924
- 700 1_
- $a Maťátková, Olga $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic $1 https://orcid.org/0000000236469738 $7 jo2017970315
- 700 1_
- $a Masák, Jan $u Department of Biotechnology, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic $1 https://orcid.org/0000000164840824
- 700 1_
- $a Šícha, Václav $u Chemistry Department, Faculty of Science, Jan Evangelista Purkyně University in Ústí nad Labem, Pasteurova 15, 400 96 Ústí nad Labem, Czech Republic $1 https://orcid.org/0000000331631764 $7 jx20100623017
- 773 0_
- $w MED00184066 $t Pharmaceuticals $x 1424-8247 $g Roč. 15, č. 5 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35631360 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20230601084518 $b ABA008
- 999 __
- $a ind $b bmc $g 1816532 $s 1168548
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 15 $c 5 $e 20220426 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
- GRA __
- $a CZ.02.1.01/0.0/0.0/17_048/0007411 $p European Regional Development Fund ERDF/ESF Project "UniQSurf - Centre of biointerfaces and hybrid functional materials"
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000729 $p European Regional Development Fund; OP RDE
- GRA __
- $a 61388963 $p RVO project
- LZP __
- $a Pubmed-20220718